Tuesday 13 May, 2025 10:04 AM
Site map | Locate Us | Login
   Jindal Poly Films' subsidiary to undertake Rs 700 crore capex for setting up new film lines    DCX Systems edges higher after bagging export order from various international clients    Morepen Labs slides as Q4 PAT decline 29% YoY to Rs 20 crore    Happiest Minds Technologies Ltd Falls 1.5%    Sun Pharmaceutical Industries Ltd Spurts 2.83%, BSE Healthcare index Rises 1.26%    Allied Blenders' board to mull fund-raising plan on 15 May    Newgen Software Tech gains after arm secures $1.63 million contract    Man Industries hits the roof after PAT rises nearly 3x YoY to Rs 68 crore in Q4    Piramal Pharma gains after receiving EIR for Turbhe facility from USFDA    Wanbury spurts after Tanuku facility clears ANVISA inspection with zero observations    K P R Mill Ltd leads losers in 'A' group    Bajaj Electricals soars after strong Q4 performance    Dr Reddys Lab jumps after Q4 PAT rises 22% YoY    Venkys (India) slides after Q4 PAT tumble 60% YoY to Rs 13 cr    Premier Explosives Ltd leads losers in 'B' group 
Saravan Stocks
       
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Lupin, Tata Chemicals, Divgi TorqTransfer, Surya Roshni to be watched
14-Mar-23   08:51 Hrs IST

Lupin: Global pharma major Lupin announced that the United States Food and Drug Administration (USFDA) has completed an inspection of its Bioresearch Centre in Pune. The inspection closed without any observation.

Tata Chemicals: Fitch Ratings revised the outlook on the company's Long-Term Foreign-Currency Issuer Default Rating (IDR) to Positive from Stable and affirmed the rating at 'BB+.

GAIL (India). The company has declared interim dividend for FY 2022-23 of 40% on the paid-up equity share capital, which is Rs 4 per equity share, with a record date of 21 March 2023.

Divgi TorqTransfer Systems: Shares of the auto component maker will debut on the bourses today, 14 March 2023. The issue price is Rs 590 per share. The IPO was subscribed 5.44 times.

Krsnaa Diagnostics: The company has operationalized 100 more pathology collection centers to provide services of Lab Investigation Facilities under Hinduhridaysamrat Balasaheb Thakeray Chikitsa for BMC Dispensaries and Hospitals in Mumbai. With this, the company has operationalized 300 pathology collection centers.

B.L. Kashyap and Sons: The company has secured new orders from domestic unrelated clients aggregating to Rs. 158 crores approx., excluding GST.

Surya Roshni: The company received orders amounting to Rs. 96.39 crores (including GST) for supply of 3LPE coated Line pipes from HPCL for City Gas Distribution projects in three geographical areas in the state of Rajasthan, Bihar, Jharkhand and West Bengal.

CreditAccess Grameen: The country's largest Non-Banking Financial Company-Micro Finance Institution (NBFC-MFI) crossed a milestone of Rs 20,000 crore Assets under Management (AUM). The AUM of the company as on 31 December 2022 was Rs 17,786 crore.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 40814173
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd